Atherosclerosis, coronary artery disease | Best Researcher Award

Posted on by sciencefatherLeave a Comment on Atherosclerosis, coronary artery disease | Best Researcher Award

Mrs. AgnΔ— LiuizΔ— | Atherosclerosis, coronary artery disease | Best Researcher Award

PhD student, cardiologist, Department of Biochemistry, Lithuanian University of Health Sciences, Kaunas, Lithuania.

AgnΔ— LiuizΔ— (Abramaviciute) is a cardiologist and PhD student at the Lithuanian University of Health Sciences, Kaunas, Lithuania. She completed her Master’s degree in Medicine and obtained her medical doctor qualification in 2017. In 2021, she achieved professional cardiologist qualifications and passed the European General Examination in Cardiology. AgnΔ— is currently pursuing PhD studies in the Department of Biochemistry, focusing on the molecular mechanisms underlying atherosclerosis. Alongside her academic work, she practices cardiology at Kaunas Clinics, contributing to both clinical care and research. AgnΔ— has authored six scientific publications and is passionate about advancing cardiovascular medicine, particularly in understanding the complex biochemical factors influencing cardiovascular diseases. She aims to improve patient outcomes through her research on oxidative stress, inflammation, and endothelial damage.

Education

AgnΔ— LiuizΔ— graduated from the Lithuanian University of Health Sciences Hospital in 2017 with a Master’s degree in Medicine, which also qualified her as a medical doctor. She obtained her professional cardiologist qualification in 2021 after completing residency training. During this time, she also passed the European General Examination in Cardiology, marking a significant milestone in her academic and clinical journey. In October 2023, AgnΔ— began her PhD studies at the Department of Biochemistry, Lithuanian University of Health Sciences. Her research focuses on exploring the role of cellular matrix proteins, cytokines, and oxidative stress in cardiovascular disease development, particularly atherosclerosis. AgnΔ— has always demonstrated a strong commitment to advancing her knowledge in both clinical practice and scientific research, ensuring a balanced approach to her academic and medical career.

Experience

AgnΔ— LiuizΔ—’s clinical career began in 2021 when she obtained her professional cardiologist qualification. From September to December 2021, she worked as a cardiologist at Kaunas Hospital, Lithuanian University of Health Sciences Hospital. Since January 2022, she has been employed as a cardiologist at the Kaunas Clinics, Lithuanian University of Health Sciences Hospital. Her clinical experience has allowed her to apply her medical knowledge to diagnosing and treating cardiovascular diseases while collaborating closely with multidisciplinary teams. In parallel with her clinical work, AgnΔ— has focused on her PhD studies in the Department of Biochemistry, further enhancing her expertise in cardiovascular research. Her academic experience, combined with hands-on clinical practice, allows AgnΔ— to contribute significantly to both patient care and scientific advancements in the field of cardiology. She continues to make an impact in both the clinic and the laboratory through her research on atherosclerosis.

Research Focus

AgnΔ— Liuizė’s research focuses on the molecular mechanisms involved in the development of atherosclerosis. Specifically, her PhD project examines the role of cellular matrix proteins, including thrombospondins, which are involved in tissue remodeling and fibrosis. She investigates the inflammatory markers and cytokines, such as GDF-15, TNF-alpha, and TGF-beta, which play key roles in cardiovascular diseases. Additionally, AgnΔ— explores endothelial damage markers like endocan and vimentin, which are important for understanding vascular injury. Her research also delves into oxidative stress, measuring markers like protein carbonyls, oxidized lipoproteins, and paraoxonase-1 (POX-1), which contribute to the pathological processes in atherosclerosis. By investigating these molecular markers, AgnΔ— aims to identify potential therapeutic targets for improving cardiovascular health and preventing atherosclerosis-related complications. Her research is not only relevant to understanding disease mechanisms but also critical in advancing diagnostic and therapeutic strategies for cardiovascular patients.

Publications:

  1. TGF-Ξ² Isoforms and GDF-15 in the Development and Progression of Atherosclerosis πŸ“–
  2. Novel Knowledge about Molecular Mechanisms of Heparin-Induced Thrombocytopenia Type II and Treatment Targets πŸ’‰
  3. Relationship between Oxidative Stress and Left Ventricle Markers in Patients with Chronic Heart Failure πŸ’”

Funda Başyiğit | Cardiology | Best Researcher Award

Posted on by sciencefatherLeave a Comment on Funda Başyiğit | Cardiology | Best Researcher Award

Assoc Prof Dr Funda Başyiğit | Cardiology | Best Researcher Award

Cardiology at Ankara Etlik City Hospital in Turkey

Dr. Fikret Başyiğit is an esteemed cardiologist with over 22 years of experience in diagnosing and treating cardiovascular conditions. He specializes in interventional cardiology with a proven track record of advanced interventional procedures. His expertise spans preventive cardiology, echocardiography, and invasive cardiology, offering comprehensive patient care. Currently an Associate Professor at Ankara Etlik City Hospital, he has held various consultant positions across prominent hospitals in Turkey. Dr. Başyiğit is also an active researcher and has published numerous influential papers on topics like myocardial infarction and coronary artery disease. He is dedicated to staying at the forefront of cardiology research and innovations, aiming to advance both clinical practices and patient outcomes.

Profile

Strengths for the Award

  • Extensive Experience: With over two decades of experience in cardiology, including expertise in preventive and invasive cardiology, the candidate has demonstrated a broad range of skills in the field.
  • High Publication Volume: The individual has co-authored numerous peer-reviewed articles in reputable journals, focusing on various aspects of cardiology such as myocardial infarction, coronary artery disease, and advanced cardiac imaging techniques.
  • Cutting-edge Research: Their work on serum pleiotrophin levels, thrombus burden, and the predictive value of novel scores for cardiac conditions showcases a commitment to advancing medical knowledge.
  • Collaborative Projects: The person has collaborated with a diverse group of specialists, which adds credibility to their ability to work within multidisciplinary teamsβ€”vital for research development.
  • Academic Leadership: The current role as an Associate Professor and experience in leading complex interventional procedures suggest both academic and practical expertise.

Areas for Improvement

  • Citations and Impact: Although there are citations associated with the individual’s work, increasing the impact factor of their research and gaining more citations could strengthen their case for awards.
  • Further Innovation: Expanding the scope of research beyond current themes to include more innovative or emerging topics within cardiology, such as AI integration or personalized medicine, could enhance the overall research impact.

EducationΒ 

Dr. Fikret Başyiğit earned his undergraduate degree in Medicine from Hacettepe University’s Faculty of Medicine (English) between September 1996 and June 2002. Following this, he pursued specialized postgraduate training at YΓΌksek Δ°htisas Training and Research Hospital, focusing on cardiology from October 2002 to March 2008. His in-depth education and training have equipped him with comprehensive knowledge in cardiovascular health, diagnostics, and therapeutic interventions. This robust academic foundation has paved the way for his clinical success and contributions to cardiology, especially in invasive cardiology and myocardial research. With ongoing dedication to learning and advancement, Dr. Başyiğit continually integrates the latest developments in the field into his practice, ensuring the highest standard of patient care and clinical outcomes.

Research FocusΒ 

Dr. Fikret Başyiğit’s research is primarily centered on cardiovascular disease, myocardial infarction, and coronary artery disease. His work delves into the relationship between biomarkers like serum pleiotrophin levels and clinical outcomes in patients with non-ST-segment elevation myocardial infarction. Additionally, he explores advanced diagnostic tools like echocardiography and the predictive value of various scoring systems in determining thrombus burden. Another focus area is preventive cardiology, examining factors like neutrophil to HDL-C ratios and their association with coronary artery stenosis. Dr. Başyiğit has also contributed research on innovative imaging techniques for mitral annulus perforation and the effects of implantable cardioverter defibrillators. His research not only advances understanding but also informs better clinical strategies to improve cardiovascular health outcomes.

Publication

  • πŸ“ The Relationship Between SYNTAX II Score and Serum Pleiotrophin Level in Patients with Non-ST-Segment Elevation Myocardial Infarction (2023)
  • πŸ“ 3-Dimensional Images of Mitral Annulus Perforation: An Alien’s Mouth (2022)
  • πŸ“ The Predictive Value of MAPH Score for Determining Thrombus Burden in Patients with Non-ST Segment Elevation Myocardial Infarction (2022)
  • πŸ“ Association of Serum Pleiotrophin Levels with Acute Coronary Syndrome (2022)
  • πŸ“ The Role of Serum Resolvin D1 Levels in Determining the Presence and Prognosis of ST-Segment Elevation Myocardial Infarction (2022)
  • πŸ“ Relationship Between the Neutrophil to HDL-C Ratio and Anatomical Significance of Coronary Artery Stenosis in Patients with Documented Myocardial Ischemia (2022)
  • πŸ“ Effect of Implantable Cardioverter Defibrillator Implantation on Frontal QRS-T Angle (2022)
  • πŸ“ Serum Thiol Levels and Thiol/Disulfide Homeostasis in Patients with Rheumatic Mitral Valve Disease and Healthy Subjects (2021)
  • πŸ“ Can Hemodialysis Change QRS Axis in Patients Without Cardiovascular Disease? (2018)
  • πŸ“ Combination of Change in Hematological Parameters with Exercise Stress Test to Predict Coronary Artery Disease (2018)

Conclusion

The individual is a highly qualified and experienced cardiologist with a rich research background, making them a strong candidate for the “Best Researcher Award.” While additional citations and innovation would further solidify their standing, the depth of their work in cardiovascular research, combined with their professional roles, firmly supports their suitability for this recognition.